Covid 19: How harm reduction advocates and the tobacco industry capitalised on the pandemic to promote nicotine
BMJ
.
2021 Jun 2:373:n1303.
doi: 10.1136/bmj.n1303.
Authors
Stéphane Horel
1
,
Ties Keyzer
2
Affiliations
1
Paris, France horel@lemonde.fr.
2
Amsterdam, Netherlands.
PMID:
34078640
DOI:
10.1136/bmj.n1303
No abstract available